Home › FDA Advisory Committee Recommends The Approval Of Lesinurad For Gout Patients
 

Keywords :   


FDA Advisory Committee Recommends The Approval Of Lesinurad For Gout Patients

2015-11-03 04:41:07| drugdiscoveryonline Home Page

AstraZeneca recentlyannounced that the US Food and Drug Administration’s (FDA) Arthritis Advisory Committee (AAC) voted 10-4 to recommend the approval of lesinurad 200 mg tablets for the treatment of hyperuricemia associated with gout, in combination with a xanthine oxidase inhibitor (XOI)

Tags: committee approval patients advisory

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
16.05Eastern North Pacific Tropical Weather Outlook
16.05Amherst Label adds third Domino press
16.05Atlantic Tropical Weather Outlook
16.05Simply.TV provides metadata to Drei TV Austria
16.05Backlash as Morrisons trials sale of New Zealand lamb
16.05All4Labels Hamburg boosts productivity with automated platemaking
16.05LRS Advances Aluminum Can Recovery with EverestLabs Robot, Funded by Can Manufacturers Institute
16.05Paramount selects Vubiquity to provide managed services for MTV Japan
More »